Luigia Di Francesco Selected Research

RO3244794

2/2009

Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luigia Di Francesco Research Topics

Disease

4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2006
3	Inflammation (Inflammations) 01/2019 - 07/2008
3	Neoplasms (Cancer) 01/2015 - 04/2012
3	Carcinogenesis 01/2015 - 04/2012
2	Colonic Neoplasms (Colon Cancer) 07/2013 - 04/2012
2	Vascular Diseases (Vascular Disease) 01/2012 - 07/2008
1	Colitis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 07/2013
1	Neoplasm Metastasis (Metastasis) 07/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2012
1	Pain (Aches) 04/2010
1	Atherosclerosis 02/2009
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2008
1	Hyperplasia 07/2008
1	Hemorrhage 01/2007

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2006
4	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2019 - 01/2007
3	ProstaglandinsIBA 07/2013 - 04/2010
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019 - 07/2013
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 07/2013 - 04/2012
2	Epoprostenol ReceptorsIBA 02/2009 - 07/2008
1	Thromboxane A2 (A2, Thromboxane)IBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Cyclooxygenase 1IBA 01/2019
1	Dextran SulfateIBA 01/2019
1	ThromboxanesIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	CytokinesIBA 07/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Galectin 3 (LGALS3)IBA 07/2013
1	rofecoxib (Vioxx)FDA Link 07/2013
1	RevaceptIBA 07/2013
1	CollagenIBA 07/2013
1	Platelet-Derived Growth FactorIBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2013
1	Prostaglandins EIBA 04/2012
1	Celecoxib (Celebrex)FDA Link 04/2012
1	AntioxidantsIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2009
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 02/2009
1	RO3244794IBA 02/2009
1	Biomarkers (Surrogate Marker)IBA 07/2008

Therapy/Procedure

1	Therapeutics 01/2012